Fundz

Saguaro Closes $1.1M Start-Up Funding To Offer New Drug Discovery Technologies That Help Fight Human Disease

PRIVATEFeb 16, 2022

Amount Raised

$1.1 Million

Round Type

Seed

Quebec CityBiotechnologySoftwareMobileArtificial Intelligence

Description

Saguaro Technologies Inc. announces the closing of a $1.1M start-up financing led by a seasoned biotech investor and including non-dilutive grant funding.

Who to call at Saguaro Biosciences, and when

A new round usually means Saguaro Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Saguaro Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Saguaro Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Saguaro Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Saguaro Biosciences

Location

Quebec City, Quebec, Canada

About

Saguaro offers next-generation cell culture products that help scientists improve drug discovery success. ChromaLive is a first-of-a-kind non-toxic dye. It allows the generation of unique phenotypic signatures from microscopy images of cells, and the quantification of disease-relevant phenotypes like cellular apoptosis, stress, autophagy, and more. With its unique add-and-mix feature, ChromaLive is ideal for automation workflows, live cell painting, 3D cultures, weeks-long kinetic imaging, and patient-derived cells. We are passionate about new technologies that can improve human health. We believe that by making disruptive technologies available to drug developers around the globe, new therapies will become available to patients at a faster pace.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Saguaro Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Saguaro Biosciences's next move

See what Strategic adds

Saguaro Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.